Indian Immunologicals Limited (IIL), has signed a Memorandum of Agreement (MoA) with the Indian Council of Medical Research (ICMR) for the clinical development of India’s first codon de-optimised live attenuated Zika vaccine.
Read MoreThe campaign, symbolised by "HRx", represents a prescription for harm reduction
Read More